• Company
  About Us
  Management Team
  Board of Directors
  Collaborations
  Careers
  Contact Us
• Therapeutic Areas
  Oncology
  Publications
• Programs
  Pipeline
  mTORC1/2 inhibitor Sapanisertib
  SYK Inhibitor Mivavotinib
  Preclinical Programs
• Clinical Trials
  Clinical Trials Overview
  Expanded Access
• Investors
  Corporate Profile
  Press Releases
  Event & Presentations
  Stock Information
  Financial Information
  Overview
  SEC Filings
  Ownership Summary
  Analyst Coverage
  Corporate Governance
  Highlights
  Board of Directors
  Management Team
  Committee Composition
  Shareholder Services
  Investor FAQs
  E-mail Alerts
  Proxy & Annual Report
  Contact Us